u/stoxcraft

The stock dropped in after-hours.

Read the full article: https://www.stoxcraft.com/news/nvidia-earnings-tonight-may-2026

🔍 Full breakdown: stoxcraft.com/stocks/nvda

The beat was historic. The reaction was not.

Every metric came in above consensus. EPS beat by 10 cents. Gross margin hit 75%. Q2 guidance cleared the bar by $4 billion. The stock fell anyway.

This is what priced-to-perfection looks like. An 85% revenue jump lands as a shrug when expectations live this far into the future.

The gaming segment is officially gone

Nvidia eliminated Gaming from its financial reporting. Graphics revenue now sits inside Edge Computing alongside robotics, physical AI, and workstations. One Reddit comment summed it up perfectly. Nvidia's entire 33-year gaming revenue equals roughly five months of current AI revenue. Consumer GPUs are a side hustle now.

China is still $0

Jensen was in Beijing this week. No breakthrough. Beijing blocked chip purchases while he was physically in the country. The $50 billion annual opportunity Jensen cited on Bloomberg remains at zero on Nvidia's books.

The business delivered everything tonight. China and hyperscaler capex sustainability are the two questions the market is still waiting to answer.

Which side of that trade are you on?

Here is what the data shows.

🔍 Full breakdown: stoxcraft.com/news/mag-7-stocks-2026

Alphabet won Q1 earnings season on fundamentals. It is not particularly close.

Overall score of 9.6. Health score of 9.3. Trend reading of 9.9. Those numbers do not happen in one quarter. They reflect a business that has been building a quality profile for years and then accelerated it.

Google Cloud grew 63% to $20.03 billion against an $18.05 billion estimate. That is nearly a $2 billion beat on a single segment. Cloud operating margin expanded to 32.9%, up from 17.8% a year earlier. The growth is profitable growth. That distinction matters more than the headline number. Cloud backlog nearly doubled to $460 billion. EPS of $5.11 grew 82% year over year.

This is not a company that had one good quarter. This is a company whose AI investment is converting into profitable revenue at scale faster than anyone modeled.

The Microsoft story is the most complicated one in the group

MSFT surged around 21% from its March lows into late April. Its fundamental score sits at 6.1. Lowest of the five hyperscalers that have reported.

Azure grew 40% in Q3 FY2026. That beat the 37% consensus. Revenue of $82.9 billion beat expectations. EPS of $4.27 beat forecasts. So the quarter was genuinely strong on the numbers that get headlines.

Here is what the headlines skipped. Free cash flow dropped 22% year over year. Microsoft guided full-year 2026 capex to $190 billion. That is up 61% from 2025. A $190 billion capex commitment in a single year is not a footnote. It is a structural drag on every financial metric that drives a health score.

The gap between Microsoft's price move and its fundamental score is the widest divergence in the Mag 7 right now. The market is pricing the Azure recovery. The score is pricing the full picture.

Apple quietly upgraded into the top tier

Apple holds an overall rating of 8.6 after Q1. That puts it in the five-star tier alongside Alphabet and Nvidia. The quarter was not dramatic. Services revenue grew. Balance sheet strength held. Cash flow consistency remained intact.

That is actually the point. Apple does not need a dramatic quarter to stay at the top of the fundamental distribution. It just needs to keep doing what it does. Q1 confirmed it is still doing exactly that.

Meta and Amazon both moving in the right direction

Meta's health score reflects one of the highest cash return profiles in the entire Stoxcraft universe. Advertising revenue held up. The AI infrastructure spending is enormous but the revenue base absorbs it. Meta is not being hurt by its own investment cycle the way Microsoft is.

Amazon improved its position after AWS posted 28% cloud revenue growth. That is its fastest pace in several quarters. One quarter does not rewrite years of performance data. But the direction is consistent and clear.

Tesla improved margins and it still doesn't matter for the score

Gross margin hit 21.1% in Q1. Up 478 basis points year over year. That is a genuine positive and the market rewarded it.

But Tesla delivered 358,023 vehicles and built roughly 50,000 more than it sold. Inventory is building. Energy storage revenue declined 12%. And the risk score remains the defining factor for Tesla's overall rating. No other Mag 7 member carries the same measured volatility. Short-term margin improvement does not move that number.

Nvidia closes the Q1 cycle Wednesday

Nvidia holds an 8.8 overall rating without having reported yet. Analysts expect earnings growth above 118% and revenue growth near 79%. The four hyperscalers that reported guided collectively to $725 billion in AI infrastructure spending for 2026. That is up 77% from 2025. Nvidia is the primary destination for that spending.

If the print comes in near or above expectations, the gap between Nvidia at 8.8 and Alphabet at 9.6 gets interesting. That is the number to watch after Wednesday.

The actual ranking after five reports

Alphabet 9.6. Nvidia 8.8 pre-report. Apple 8.6. Meta and Amazon strong with room to move. Microsoft 6.1. Tesla lowest in the group.

One quarter does not close a gap built over years. But it can change the trajectory. Alphabet's Q1 did not just confirm the score. It accelerated it.

Wednesday tells us whether Nvidia does the same.

What is your read on the Nvidia print? Beat and rally or beat and sell like the last four times?

Chapter 1: The bond market just reminded everyone who is in charge

The 30-year U.S. Treasury yield hit its highest level since 2007. Oil is holding above $100. The Iran conflict is keeping inflation sticky. The Fed is now talking rate hikes instead of rate cuts.

That one shift repriced every high-multiple tech stock in a single session.

GOOGL -2.34%. AMZN -2.08%. MSFT -1.44%. TSLA -1.43%. NOW -1.54%.

This was not company-specific weakness. This was the bond market pulling the rug on the entire growth trade simultaneously. When the 30-year moves like that, the math behind every discounted cash flow model changes overnight.

Chapter 2: Nvidia sat out its own party

NVDA -0.77% on a day when its semiconductor peers were green.

That is not a coincidence. Earnings drop after close. Wall Street is expecting 78% year-on-year revenue growth. Around $78 to $80 billion. That bar is not high. It is stratospheric.

Here is the uncomfortable history. Nvidia has dropped on four of its last five earnings releases despite beating revenue estimates every single time. The whisper numbers are always higher than the published consensus. Traders know this. The -0.77% you see on the heatmap is not fear. It is profit trimming before a known risk event.

The real question is not whether Nvidia beats. It is whether the guidance decelerates. That is the only number that matters tonight.

🔍 Full breakdown: stoxcraft.com

Chapter 3: The smart money already moved

While Nvidia pulled back, INTC gained +2.43% and MU gained +2.52%.

This is not random. Institutional capital including high-profile names like Stanley Druckenmiller has been rotating out of Nvidia and into Intel and Micron to capture what they are calling the next phase of the AI boom.

The thesis is straightforward. Micron's High-Bandwidth Memory is fully booked through 2026. There is a genuine global memory crunch and Micron sits at the center of it. Intel meanwhile beat its last earnings, secured customer commitments for its 18A manufacturing node, and landed a preliminary chip deal with Apple.

The Nvidia trade is crowded. Intel and Micron are where the rotation is going.

Chapter 4: The defensive play is already happening

PG&E +3.53%. AT&T +2.25%. ExxonMobil +1.2%.

When inflation fears hit and growth tech slides, this is exactly where the money goes. Utilities become a safe haven. Energy gets a direct tailwind from oil above $100. Telecom offers yield in a rising rate environment.

The heatmap is not showing random red and green. It is showing a textbook rotation in real time. Out of duration-sensitive growth. Into yield and commodities.

The question the whole market is asking tonight

Nvidia reports in hours. If guidance holds, the growth trade breathes again and tomorrow looks different. If guidance decelerates even slightly, the bond market narrative takes over completely and this rotation accelerates.

Which way do you think it goes?

🔍 Full breakdown: stoxcraft.com/stocks/gm

The quarter was strong. The headlines around it were not.

EPS of $3.70 against a $2.62 estimate. North American margins at 10.1%. Tariff bill running $1,200 per vehicle and margins expanded anyway. On paper, one of the cleanest quarters GM has posted in years.

Then you zoom out.

20,000 salaried jobs cut across Detroit. A record privacy penalty for breaking California data laws. Silverado medium-duty trucks discontinued. A battery plant sitting paused mid-construction. These are not small footnotes. These are signals of a company making painful structural bets while trying to look confident in front of investors.

The EV chapter is getting expensive and messy

$1.1 billion in EV restructuring charges hit Q1 alone. GM has guided for more through the rest of 2026. The Cruise autonomous unit has been quiet. The battery plant pause raises real questions about whether the electrification timeline is slipping or being quietly abandoned.

The job cuts framed as AI-driven efficiency improvements are partly that. They are also partly a company acknowledging it built too much overhead for a transition that is moving slower and costing more than the original plan assumed.

What the market is actually pricing

Stock sits at $73.10. Average analyst target is $95. 19 out of 29 analysts say Strong Buy. The BuyMeter on Stoxcraft reads 6.8, firmly in Buy territory. The TrendMeter reads 3.5, a confirmed downtrend.

That gap between what analysts think GM is worth and where the stock is trading is not confusion. It is the market demanding to see whether Q1 margins hold once the $500M Supreme Court tariff refund disappears and the restructuring charges keep coming.

The real question this post wants you to answer

GM is absorbing tariffs, cutting jobs, paying privacy fines, pausing battery plants, and still beating earnings by 40%.

Is this a company executing a hard pivot under pressure? Or is it a company patching holes while the underlying transformation falls behind schedule?

The trucks are carrying everything right now. The question is how long they have to.

Drop your take below.

Revenue hit $181.5 billion, up 17% year over year. EPS came in at $2.78 against a $1.64 consensus. That is not a small beat. That is a company running leaner than Wall Street modeled.

🔍 Full breakdown: stoxcraft.com/stocks/amzn

AWS is the reason everything else gets ignored

Cloud revenue grew 28% to $37.6 billion. That is the fastest quarterly pace in 15 quarters. AWS operating income came in at $14.16 billion against a $12.84 billion estimate. The segment backlog now stands at $364 billion, with a separate $100 billion Anthropic commitment not yet included in that number.

The AI infrastructure spending wave driving AWS is the same dynamic behind Nvidia's data center numbers, Microsoft Azure's acceleration, and the broader chip boom. Amazon is not adjacent to that story. It is one of the central nodes.

The retail side is where the real surprise was

Around 70% of Amazon's marketplace sellers source from China. With tariffs elevated through Q1, many absorbed cost increases of 20 to 30% across key categories. That was the setup going into earnings. The result was North America retail operating margins expanding to 9.0%. Units grew 15%.

The tariff narrative was real. The margin collapse did not happen.

The third engine nobody talks about enough

Advertising grew 22% to $17.2 billion in Q1. Trailing twelve-month advertising revenue now exceeds $70 billion. The incremental margins on that business are software-like. It is becoming a genuine third profit engine sitting between AWS and retail, and it barely gets mentioned in the earnings coverage.

What the scores show

Amazon earns a Health Score of 8.4, placing it sixth across the full Stoxcraft universe and first within Consumer Discretionary. More than 92% of companies tracked globally score lower on fundamental quality. The Performance Score of 8.1 puts it in the top 15% of the universe. TrendMeter reads 7.4, a confirmed uptrend. BuyMeter at 6.6 sits in Buy territory.

The Risk Score of 6.0 is the honest flag. $43.2 billion in Q1 CapEx alone. Full-year spending approaching $200 billion. Tariff exposure on the marketplace side is structural, not temporary. Azure grew 40% and Google Cloud grew 63% in the same quarter AWS grew 28%. The competitive gap on growth rate has narrowed.

The actual read on this quarter

AWS accelerating at its fastest rate in four years while retail holds margin through a genuine cost shock is not a lucky quarter. It is what a well-architected business looks like when two separate segments get tested at the same time and both pass.

Q2 guidance of $194 to $199 billion in net sales is the next test. The setup coming out of Q1 gives that range real credibility.

QNX just got certified as a runtime on Nvidia's IGX Thor edge AI platform. That covers autonomous vehicles, robotics, and medical devices. The volume reaction was 497% above the 3-month daily average. That is not retail noise. That is institutional repricing.

🔍 Full breakdown: stoxcraft.com/stocks/bb

The company people think they know is not the company that exists

BlackBerry stopped making phones in 2016. What it kept was QNX, one of the only safety-certified embedded operating systems trusted across global automotive manufacturers. Reuters has documented its leading position in that category. This is not a pivot story. QNX has been the business for years. The market just stopped paying attention after the phones disappeared.

Three consecutive quarters of GAAP profitability. That means every cost covered, including stock-based compensation and depreciation. Most small-cap software companies in adjacent markets have not cleared that bar in 2026.

The backlog is the number that matters most

QNX backlog growth has held at +23% annually since 2022. In automotive software, backlog is not a leading indicator. It is committed revenue across multi-year contracts. The revenue line is growing at +10% annually. The backlog growing at more than twice that rate means the revenue line accelerates from here without needing new contracts.

That is the setup most people running a 2016 mental model of this company never see.

What the chart actually shows

Flat from June 2025 through early 2026. Drifting lower into April. Then Nvidia certified QNX and the stock went vertical in a single session. The 1-year chart is not a mystery. It is a business that traded on its legacy reputation for months and then re-rated the moment a credible third party confirmed what the fundamentals had been saying.

Where analysts sit versus where the stock is

7 analysts covering it. Average price target $4.90. Stock is at $6.18. The stock has already blown through the analyst consensus. That gap is not a warning. It is a timing signal. The models were built on the old business. The market priced the new one.

9 analysts on the rating side. 6 Hold. 2 Strong Buy. 1 Sell. Nobody is chasing it. Nobody is running from it. That is exactly where a turnaround sits before institutional capital starts moving.

The honest risk picture

Risk rating of 7.6 out of 10. This is a small-cap with limited analyst coverage and a drawdown history that goes back years. One bad quarter resets weeks of technical progress. The valuation at 27x forward earnings prices in the improvement. There is no margin for a miss.

The TrendMeter sits at 6.6, which is an active uptrend but not an extreme reading. The entry signal is Buy at 5.5. Reasonable, not stretched.

What needs to happen for this to go higher

The health rating needs to hold above 5.5 and keep improving as QNX backlog converts to recognised revenue. The performance rating needs time. The 3-year return window will mechanically start reflecting the QNX-era business in late 2026 as the device-era collapse ages out of the calculation. That alone lifts the rating without any change in the underlying business.

If the health rating crosses 6.0 while the trend signal holds above 6.0 simultaneously, BB starts building the profile of a quality compounder coming out of a long trough.

The chart was flat for months. Then Nvidia said QNX. The market is still catching up. Full stop.

MSFT posted its strongest weekly performance since 2007 after Q3 FY2026 earnings came in well above expectations. Revenue hit $82.9 billion, up 18% year over year. Operating income rose 20% to $38.4 billion. Operating margin came in at 46.3%, ahead of guidance. EPS landed at $4.27 against a $4.06 consensus. A nearly 5% beat on earnings.

None of that moved the health score. The health score runs on quarterly balance sheet and income data. It doesn't react to price. It reacts to fundamentals. And the fundamentals had already been telling this story for months.

🔍 Full MSFT screener breakdown: stoxcraft.com/stocks/msft

The numbers behind the score are worth understanding. Operating cash flow runs at approximately $136 billion on a trailing twelve-month basis. Free cash flow per share sits at $10.50. Net profit margin is 35.7%, significantly above the sector median. The Altman Z-Score is 10.1, signaling very low financial distress risk even as Microsoft commits $190 billion in capital expenditures this year.

Azure grew 40% year over year in Q3, beating Microsoft's own guidance of 37% to 38%. The AI business now runs at $37 billion annualized, up 123% from a year earlier. Commercial remaining performance obligation reached $627 billion, up 99%. Roughly a quarter of that converts to revenue over the next 12 months.

The stock came into earnings down roughly 14% year to date, sitting more than 30% below its 52-week high of $555. RSI had drifted toward oversold. The entry signal was in unattractive territory. Post-earnings, the technical picture shifted. RSI recovered toward neutral. MACD turned positive. The trend moved from downtrend to recovering uptrend.

The stock still trades roughly 25% below its 52-week high at current prices near $405. 62 analysts cover it. 50 are strong buys. Zero sells. Average price target is $559. Max target is $870. The analysts are not debating whether Microsoft goes higher. They are debating how far.

The revenue picture is straightforward. From $168 billion in 2021 to over $280 billion in 2025. Microsoft did not just grow. It doubled its revenue in four years. Every bar on the chart taller than the last. Cloud did that. AI is next.

Three things to watch going into Q4 FY2026 earnings on July 28, 2026. Azure growth guidance of 39% to 40% would mark a second consecutive quarter of acceleration. The AI revenue run rate at $37 billion annualized growing at triple-digit rates shifts the valuation story fast. And free cash flow trajectory under $190 billion in capex is the honest stress test for the whole thesis.

The price fell. The earnings did not. The revenue did not. The cloud did not. Microsoft is not a turnaround story. It never needed to be one.

XOM beat adjusted EPS by 15%. CVX posted its biggest earnings beat since October 2020. Both companies looked leaner than their headline profit numbers suggested. Both kept their dividend streaks alive. ExxonMobil extended to 43 consecutive years. Chevron raised its payout 4% to $1.78 per quarter, reaching 39 straight years.

On paper, both look fine. In the numbers, the gap is significant.

🔍 Track XOM on Stoxcraft: stoxcraft.com/stocks/xom

🔍 Track CVX on Stoxcraft: stoxcraft.com/stocks/cvx

The coverage question nobody wants to answer at $70 oil

XOM covered its $17.2B annual dividend at 3.02x on operating cash flow. For every dollar it paid shareholders, it generated three in cash from operations. That is not a tight situation. That is structural confidence built over years of cost reduction and production scale through Permian and Guyana.

CVX's free cash flow covered its dividend at 1.30x. Still positive. Still manageable. But the cushion is thin. When oil softens further, or when Hess integration synergies run behind schedule, 1.30x becomes uncomfortable quickly.

XOM has stated it can protect its dividend with oil below $40 per barrel. CVX targets a combined capex and dividend breakeven below $50 Brent. That is still a reasonable threshold. But it sits a full tier above XOM's. At $70 oil, neither company is in trouble. But one of them is watching the margin narrow faster.

CVX is not the villain here

This is where most of these comparisons go wrong. Chevron is a well-run company with a genuinely strong balance sheet and a management team that has prioritized income investors for four decades. The 39-year streak is not an accident. It is discipline.

The issue is not whether CVX is good. It is whether the "CVX is the safer dividend" narrative that has circulated for years actually holds up when you stress test the coverage numbers at lower oil prices. The data says it does not hold up as cleanly as the narrative suggests.

CVX is not weak. It is the lower-cushion bet waiting for oil to cooperate.

What the energy sector actually looks like right now

Only 3 of 15 tracked energy stocks show a positive trend signal. The most common entry classification across the sector is Hold. The sector is financially healthy but losing price momentum. Balance sheets are strong after years of debt paydown. Stock performance is another story.

ConocoPhillips sits at the top of the sector on fundamentals. EOG holds up well as the cleanest pure upstream play. XOM leads integrated oil. CVX trails all three on financial strength scores.

SLB is the one name worth flagging as a concern. Down around 12% over the past year, up only 38% over five years. Oil majors are cutting services budgets first when prices get tight. SLB feels that immediately.

The actual decision

For reliability: XOM. Forty-three years, 3.02x coverage, sub-$40 breakeven. The dividend is as close to guaranteed as anything in the energy sector gets.

For yield: CVX. The 3.5 to 4% yield is real income today and the company has every intention of maintaining it.

Knowing which one matters more to your portfolio is the decision. Both are Buy-rated. The gap between them is not about quality. It is about how much cushion you need when oil stops cooperating.

Full stop.

QCOM -11.46%. That is the headline. Qualcomm just had its worst single session since 2020, and it did not happen in a vacuum. The stock had surged over 60% in a matter of weeks. A hotter-than-expected inflation print and fresh fears around the U.S.-Iran ceasefire were the match.

The overvaluation was already the fuel. INTC followed at -6.82%, dragged down by the same wave plus a KeyBanc report flagging a 27% month-over-month drop in laptop shipments. MU -3.61%, AMD -2.29% all caught the same exit.

🔍 Track every name on this heatmap: stoxcraft.com

But NVDA? +0.61%. Held its ground while everything around it bled. At its size, that is not nothing. The market is still not ready to let Nvidia go.

On the consumer side, NFLX +2.59% was a quiet bright spot. AAPL managed +0.72%. TSLA gave back -2.60% with no real catalyst, just noise riding the broader risk-off mood.

Utilities and telecoms were the safe corner of the room. AT&T +1.45%, PG&E +3.70%. When chips bleed, people rotate somewhere boring. Today it was there.

The day belonged to the inflation report and the chip unwind. Full stop.

Okay so I've been looking at Astera Labs for the past few days and I genuinely don't know what to do with this stock right now.

The momentum is real. TrendMeter maxed out. Performance score in the top 5% of the entire market. Earnings beat estimates every single quarter going back to Q2 2025. Revenue nearly doubled last year, approaching a billion. 17 strong buys out of 27 analysts, zero sells. On paper, this thing looks unstoppable.

But then you look at where the revenue actually comes from.

32% Singapore. 30% China. 29% Taiwan. Three percent United States.

That's 91% of revenue concentrated in the exact geography that's been the center of every trade war headline for the last two years. One product. One bet. And almost none of it in the country where the stock trades.

And I'm not seeing anyone talk about this. The bull case is all AI data center spending, hyperscaler capex, connectivity chip demand. Which is all real. But if something goes sideways with Taiwan, or China gets hit with another round of restrictions, or Singapore-based customers pull back, this company has no fallback. There's no domestic revenue cushion.

The P/E has been compressing every quarter since Q1 2025, which is the one genuinely good news story here. It's still expensive but less obviously insane than it was. And the analysts clearly believe in the growth trajectory.

I'm probably overthinking this. The AI infrastructure build-out is real and ALAB sits right in the middle of it. But buying something up 94% in a month with that geographic concentration after tariffs have already rattled supply chains... I can't convince myself that the risk score of 8.7 is wrong.

Been looking at this on stoxcraft.com if anyone wants the full breakdown. Curious if others are actually pricing in the Asia-Pacific concentration or just riding the trend.

🔍 Full ALAB screener breakdown: stoxcraft.com/stocks/alab

The narrative around Intel and AMD has shifted dramatically over the past five years. AMD took the performance crown in consumer CPUs. Its Ryzen lineup won over gamers, developers, and data center buyers. The momentum has been clearly in AMD's favor for years. Yet Intel's market cap still sits above AMD's. That is not a mistake. It is a reflection of scale, installed base, and the slow-moving nature of enterprise technology cycles.

Intel at $51B still commands a premium over AMD at $22B despite underperforming on almost every product benchmark that matters to enthusiasts. The reason is simple. Enterprise and government contracts move slowly. Most corporate fleets still run Intel. Most servers still run Intel. That installed base does not flip overnight regardless of what the benchmark sheets say.

🔍 Full INTC screener breakdown: stoxcraft.com/stocks/intc

🔍 Full AMD screener breakdown: stoxcraft.com/stocks/amd

The Stoxcraft scores tell a more nuanced story. Intel carries a Health Score of 1.2 and a Risk Score of 6.4. The fundamentals are under real pressure. The performance score of 9.6 reflects recent price momentum, not business strength. AMD's profile is different. The underlying business is in better shape even if the market cap does not reflect it yet.

Visa sits at $49B with a Health Score of 9.2. That is a business printing money on every transaction globally with almost no direct exposure to tariffs or hardware cycles. It is one of the cleanest business models in the market.

Amazon at $36B in this comparison and Broadcom up 4.23% on the day round out a group of five companies that look similar on market cap but could not be more different in their risk profiles and growth trajectories.

The lesson here is straightforward. Market cap tells you what the market currently believes. The scores tell you whether that belief is justified. Intel being larger than AMD by market cap is not a signal to buy Intel. It is a signal to look deeper at what is actually holding that valuation up and how long it can last.

Popularity is not valuation. AMD is proof of that in one direction. Intel is proof of it in the other.

The Q1 2026 numbers were not the story. Revenue came in around $92.9B, broadly in line with consensus. Operating businesses performed as expected. Insurance held up. BNSF and Berkshire Hathaway Energy contributed steady cash flow. Nothing broke. Nothing surprised.

The only number that matters is $330B. That is the cash and Treasury bill position Berkshire is sitting on right now. It is a new all-time record by a significant margin. For context, the 2019 peak was $128B. The current pile is more than double that. And in 2019, a sharp global selloff followed within months.

🔍 Full BRK-B screener breakdown: stoxcraft.com/stocks/brk-b

The pattern has shown up before. Cash peaked at $44B in 2007 before the financial crisis. It peaked at $128B in 2019 before the COVID selloff. Buffett does not time markets. But the cash builds when he cannot find anything worth buying at current prices. That tells you something about how he sees valuations right now.

What makes this different from prior cycles is the interest rate environment. Buffett is earning real returns on those Treasuries. The cost of waiting is lower than it was in 2019 when rates were near zero. That means he can afford to be more patient this time. And he is.

BRK-B carries a Risk Score of 1.7 out of 10 on Stoxcraft, placing it in the lowest decile for volatility across the entire universe of tracked stocks. Health Score is 8.5. The BuyMeter rates it a Buy driven by fundamental strength and analyst consensus, not momentum.

Apple remains Berkshire's largest equity holding. Whatever happens to AAPL shows up directly in Berkshire's reported portfolio value each quarter. That is a secondary variable worth tracking alongside the cash position.

The question every investor is asking is not whether Buffett will deploy the $330B. He will. The question is when and where. Because when that capital moves, it will not move quietly.

Berkshire is not a distressed bet. It is the most patient money in the market waiting for the right moment.

SHOP reported Q1 2026 results with total revenue of $3.13B, down 16% from the prior quarter but that comparison is misleading. Q4 is seasonally Shopify's strongest quarter every year due to holiday commerce volume. The relevant comparison is year over year, and the growth trajectory has not broken.

The business model is straightforward. 76% of revenue comes from Merchant Solutions, meaning Shopify earns when its merchants earn. Subscriptions make up the remaining 24%. That alignment between platform and merchant success is what makes the model defensible. When merchants grow their GMV, Shopify's revenue follows automatically.

🔍 Full SHOP screener breakdown: stoxcraft.com/stocks/shop

Geography is where the long-term case gets interesting. 63% of revenue is still US-based. EMEA accounts for 21%. APAC, Canada, and Latin America combined make up the rest. The international expansion runway is significant and largely untapped. Shopify has barely scratched the surface of what global commerce could mean for the top line over the next five years.

The profitability picture is the honest tension in the thesis. Gross profit is solid but expenses and adjustments are eating into net income. Q1 2026 net income came in at negative $572.95M. Shopify is still in investment mode. The market is pricing in a future where those investments pay off. The risk is that timeline extends further than expected.

Analyst sentiment has not moved. 35 out of 52 analysts rate it a strong buy. Only one rates it a strong sell. The consensus price target sits at $153.87 against a current price of $105.44. That is a 46% gap between where the stock trades and where analysts think it belongs within 12 months. The max target sits at $199.95.

The P/E has expanded every year since 2021 as revenue compounded. The market is not paying for today's earnings. It is paying for the commerce infrastructure Shopify is building underneath millions of merchants globally.

Next earnings report is July 29, 2026. Between now and then, the question is whether free cash flow margin shows meaningful progress. That is the metric that closes the gap between growth stock and profitable platform. Until it does, the stock stays volatile and the opportunity stays open.

AAPL has posted negative annual returns exactly twice in the last decade. -6% in 2018 during the US-China trade war. -26% in 2022 during the rate hike cycle. Every other year was positive. 2019 returned 86%. 2020 returned 80%. 2023 returned 48%. The 10-year average sits at 33% per year.

The current pullback is being driven by tariff exposure, not fundamental deterioration. Over 90% of iPhones are still assembled in China, and US tariffs are adding an estimated $150 to $200 per device in production costs. That is a real headwind. It is also a known one. Markets that fully price in a known risk tend to react sharply when reality turns out better than feared.

🔍 Full AAPL screener breakdown: stoxcraft.com/stocks/aapl

Apple reported Q1 2026 earnings on April 29. Revenue came in above consensus. Services continued growing. The balance sheet still holds over $160B in gross cash. The company did not raise iPhone prices despite the tariff pressure, which means the balance sheet absorbed the hit. For now.

Health Score sits at 8.1 out of 10. Risk Score is 2.3, placing it in the lowest quartile for volatility across the Stoxcraft universe. The BuyMeter classifies it as a Buy.

The pattern across 10 years is consistent. Bad years happen. They have not lasted. The two down years were followed by some of the strongest recoveries in the stock's history.

The tariff situation is not resolved. But Apple has navigated trade wars before. The 2018 playbook ended with an 86% return the following year.

History does not guarantee anything. But ignoring it is also a choice.

AAPL has posted negative annual returns exactly twice in the last decade. -6% in 2018 during the US-China trade war. -26% in 2022 during the rate hike cycle. Every other year was positive. 2019 returned 86%. 2020 returned 80%. 2023 returned 48%. The 10-year average sits at 33% per year.

The current pullback is being driven by tariff exposure, not fundamental deterioration. Over 90% of iPhones are still assembled in China, and US tariffs are adding an estimated $150 to $200 per device in production costs. That is a real headwind. It is also a known one. Markets that fully price in a known risk tend to react sharply when reality turns out better than feared.

🔍 Full AAPL screener breakdown: stoxcraft.com/stocks/aapl

Apple reported Q1 2026 earnings on April 29. Revenue came in above consensus. Services continued growing. The balance sheet still holds over $160B in gross cash. The company did not raise iPhone prices despite the tariff pressure, which means the balance sheet absorbed the hit. For now.

Health Score sits at 8.1 out of 10. Risk Score is 2.3, placing it in the lowest quartile for volatility across the Stoxcraft universe. The BuyMeter classifies it as a Buy.

The pattern across 10 years is consistent. Bad years happen. They have not lasted. The two down years were followed by some of the strongest recoveries in the stock's history.

The tariff situation is not resolved. But Apple has navigated trade wars before. The 2018 playbook ended with an 86% return the following year.

History does not guarantee anything. But ignoring it is also a choice.

Everyone has been calling the top on Google Search for two years. AI is killing it. ChatGPT is eating its lunch. The queries are migrating.

Q1 2026 just closed that debate again.

Search brought in $60.4B, up 19% year over year. That's faster than Q4 2025. Queries hit an all-time high, per Sundar Pichai himself. AI Overviews and AI Mode are pulling more searches in, not diverting them.

Cloud was the real headline though. $20B. Up 63%. Well ahead of estimates. Operating margin expanded to 36.1%.

On Stoxcraft, GOOG holds a Health Score of 8.9 out of 10. Top 8% globally across roughly 3,900 tracked stocks. The score was already signalling strength before earnings confirmed it.

The one risk worth watching is the DOJ antitrust appeal. That's the open question. Not the AI thesis that keeps getting disproved every quarter.

Full breakdown here: https://www.stoxcraft.com/news/alphabet-q1-2026-earnings-google-search-grew-19-while-the-ai-panic-spread

Eli Lilly reported Q1 2026 on April 30 and it was not close. Revenue came in at $19.8 billion, up 56% year over year and well above the $17.6B consensus. Adjusted EPS hit $8.55 against an estimate of $6.66. That is a 28% beat on earnings. The stock surged over 9% on the day, its biggest single session move in nearly three months.

The entire story runs through two drugs. Mounjaro revenue rose 125% to $8.7 billion globally. Zepbound revenue grew 80% to $4.16 billion in the U.S. Together they generated more than $12 billion in a single quarter. Volume grew 65% across the portfolio, and even with a 13% price headwind from lower realized prices, gross margin held. The volume more than absorbed the pressure.

🔍 Full LLY screener breakdown: stoxcraft.com/stocks/lly

Management raised full year 2026 guidance on both lines. Revenue guidance lifted to $82B to $85B, up from $80B to $83B. Adjusted EPS now sits at $35.50 to $37.00, up from $33.50 to $35.00. Both ranges land above where Wall Street was heading into the print.

The next growth lever has not even shown up in the numbers yet. Foundayo, Lilly's oral GLP-1 pill for obesity, launched in Q2, meaning its sales were not included in this report. If the pill gains commercial traction it opens a completely different patient population that cannot or will not inject. Early rollout has been described as muted but the pipeline opportunity is real.

The risk worth watching is pricing. U.S. Zepbound prices are relatively stable following the cash and government channel price reset, but commercial insurance pricing trends still need monitoring. If private payer prices drift toward cash pay benchmarks, the margin story gets more complicated in the back half of the year.

The stock came into earnings down over 21% YTD, mostly macro and valuation pressure, not fundamental deterioration. This print made the case that the fundamentals were never the problem.

Amazon has been one of the quietest stories in mega-cap tech this year and one of the strongest. The stock is up over 30% in the past month alone, driven by AWS momentum, advertising growth, and a string of AI infrastructure deals that are reshaping how the market thinks about this business.

Tonight the numbers have to show up.

Consensus expects revenue of roughly $177B, up ~13% year-over-year, with AWS expected to grow around 26%. The more aggressive call - UBS is projecting 38% AWS growth in 2026 - is what moves the stock if it proves closer to right. Advertising revenue is forecast around $16.8B, up 21%. The P/E has already compressed from ~50x in Q2 2024 down to ~30x by Q4 2025, so the valuation setup is meaningfully better than it was a year ago.

🔍 Full AMZN screener breakdown: stoxcraft.com/stocks/amzn

The revenue mix tells the real story of what Amazon has become. Online stores are still the largest segment but AWS and advertising are where the margin lives. Amazon committed $25B to Anthropic, signed agentic AI deals with Meta to run workloads on Graviton chips, and is guiding $200B in total capex for 2026. It is building infrastructure at a scale very few companies can match.

Q4 2025 was the one blemish in an otherwise clean earnings run - net income missed despite strong AWS and advertising. The market will be watching Q2 guidance closely, particularly operating income, which some analysts expect could come in below consensus even if revenue holds.

Analyst consensus is Strong Buy. Average price target sits at $283, with the street high at $360.

The business is as diversified and well-positioned as it has ever been. Tonight is about whether the numbers match the setup.

Tesla reported Q1 2026 on April 22 and the result was classic Tesla -- beat where it mattered, miss where it didn't, and then drop a number on the call that changed the entire conversation.

EPS came in at $0.41 non-GAAP against a $0.36 expectation. Gross margin jumped to 21.1%, up 478 basis points year over year -- the strongest reading in a while. Free cash flow turned positive when the market had been bracing for negative. Stock popped 3.6% after hours.

Then the call happened.

Capex guidance was raised to over $25 billion for the full year, up from the prior $20 billion estimate. Six factories, AI infrastructure, Optimus production setup, and a semiconductor research fab in Texas. Management confirmed negative free cash flow for the remainder of 2026. The after-hours gain faded.

🔍 Full breakdown and valuation analysis: stoxcraft.com/news/tesla-q1-2026-earnings-pe-ratio-valuation

Two things worth flagging on the quality of the beat. Auto gross margin improvement was aided by roughly $230M in one-time warranty true-downs and tariff relief. Energy storage margin included approximately $250M in one-time tariff recognitions from prior quarters. Strip those out and the underlying numbers are thinner than the headline suggests. Q2 is the real test.

On the forward story: robotaxi operations expanded to Dallas and Houston, FSD approval came through in the Netherlands and China, and Cybercab production has just started. Musk was direct that robotaxi revenue will not be material in 2026. The real bet is on 2027 and beyond.

At 181x earnings with confirmed negative free cash flow through year-end and one-time items propping up margins, the valuation still requires belief in the longer arc -- Optimus, Cybercab, unsupervised FSD at scale. Whether you hold that belief or not is the entire TSLA thesis right now.

INTC +22.70%. Intel posted numbers the market had given up expecting. Whatever they reported, it was enough to shake off months of doubt in a single session. AMD +13.33% followed right behind -- when Intel beats, the whole chip space gets a repricing. LRCX +4.64%, MU +3.30%, KLAC +4.83% all caught the wave. NVDA held steady at +1.47%, which at its size is a statement in itself.

🔍 Track every name on this heatmap: stoxcraft.com

On the other side of the map, Health Technology got hit hard. LLY dropped -4.48% -- the biggest red square in the room today. MRK -2.03%, ABBV -0.91%. No single catalyst dominated but sector rotation out of pharma was visible all session.

Financials were quiet and slightly red across the board. JPM -0.52%, GS -1.01%, Visa -0.56%. Not a collapse, just no reason to be there when semis were moving like this.

AMZN +2.36% and META +1.18% kept consumer tech respectable. GOOGL was effectively flat at +0.07% -- holding ground ahead of its own earnings.

The day belonged to Intel and AMD. Full stop.